Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

202511 citationsJournal Articlehybrid Open Access

Authors

Long-term use of mepolizumab to treat EGPA was well tolerated and resulted in sustained reductions in OCS use.

Published in: Arthritis & Rheumatology

Volume 77, Issue 8, pp. 1052-1062

Field-Weighted Citation Impact: 19.00